MPO and COVID-19: Finally, recent research suggests that severe hypouricemia can cause endothelial dysfunction, lower blood pressure, reduce myeloperoxidase activity and promote lipid peroxidation in healthy individuals, which could worsen the outcome of COVID-19 patients with low uric acid levels [57].